CoChat

A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro‐cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients

Open access
Zhao, J., Zheng, X., Chu, H., Zhao, J., Cong, Y., Fried, M., Fox, M., Dai, N. · 2014 · Neurogastroenterology & Motility
Cited by 67

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background: Small intestinal bacterial overgrowth ( SIBO ) may be a cause of irritable bowel syndrome ( IBS ); however, current investigations have important limitations. We aimed to identify clinically relevant diagnostic criteria for SIBO based on lactulose hydrogen breath test ( LHBT ) alone and combined with scintigraphic measurement of oro‐cecal transit ( SOCT ). Methods: Results of LHBT / SOCT investigation from 89 IBS patients and 13 healthy volunteers were included in a systematic analysis of six published criteria for SIBO diagnosis. Clinical relevance of competing criteria was determined by assessing (i) prevalence of SIBO in IBS patients and healthy volunteers (ii) if SIBO diagnosis predicted improvement in IBS symptoms in a prospective, pilot therapeutic trial of a non‐absorbable antibiotic (rifaximin 600 mg b.d.) in IBS patients. Key Results: Reproducibility of SIBO diagnosis by combined LHBT / SOCT was near perfect. A ≥5 ppm H2 increase prior to appearance of cecal contrast was detected in more IBS patients than healthy volunteers (35/89 vs 1/13; p = 0.026), but not for other diagnostic criteria. IBS patients with SIBO , compared to those without SIBO , reported significantly greater improvement in abdominal symptoms following rifaximin therapy ( p < 0.002 overall IBS symptom severity). This improvement was most marked in D‐ IBS patients in whom all symptoms improved, including stool frequency and consistency (all p < 0.004). Conclusions & Inferences: Combined LHBT / SOCT testing using a H2 5 ppm cutoff may identify a subgroup of IBS patients with SIBO . Pilot data examining the clinical response to rifaximin suggest that this subset of IBS patients may benefit more than those with a normal test.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nmo.12331

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

Metadata

Authors
Zhao, J., Zheng, X., Chu, H., Zhao, J., Cong, Y., Fried, M., Fox, M., & Dai, N.
Venue
Neurogastroenterology & Motility
Publisher
Wiley
Published
2014-03-18
Volume
26
Issue
6
Pages
794-802
ISSN
  • 1350-1925 (ISSN-L)
  • 1365-2982
OpenAlex
W2032339519
Cited by
67
References
11
FWCI
5.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.